{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:01:05Z","timestamp":1772121665006,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,11,12]],"date-time":"2005-11-12T00:00:00Z","timestamp":1131753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00277-005-1080-y","type":"journal-article","created":{"date-parts":[[2005,7,25]],"date-time":"2005-07-25T12:55:57Z","timestamp":1122296157000},"page":"816-822","source":"Crossref","is-referenced-by-count":43,"title":["Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard\u2013Soulier syndrome"],"prefix":"10.1007","volume":"84","author":[{"given":"Margareth Castro","family":"Ozelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Svirin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubov","family":"Larina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,12]]},"reference":[{"key":"1080_CR1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2004.00759.x","volume":"2","author":"T Abshire","year":"2004","unstructured":"Abshire T, Kenet G (2004) Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2:899\u2013909","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"1080_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000057301","volume":"32","author":"M Aldouri","year":"2002","unstructured":"Aldouri M (2002) The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb 32(Suppl 1):41\u201346","journal-title":"Pathophysiol Haemost Thromb"},{"key":"1080_CR3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2141.2003.04286.x","volume":"121","author":"AM Almeida","year":"2003","unstructured":"Almeida AM, Khair K, Hann I, Liesner R (2003) The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 121:477\u2013481","journal-title":"Br J Haematol"},{"key":"1080_CR4","first-page":"860","volume":"87","author":"CL Balduini","year":"2002","unstructured":"Balduini CL, Iolascon A, Savoia A (2002) Inherited thrombocytopenias: from genes to therapy. Haematologica 87:860\u2013880","journal-title":"Haematologica"},{"key":"1080_CR5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0950-3536(89)80035-6","volume":"2","author":"MC Berndt","year":"1989","unstructured":"Berndt MC, Fournier DJ, Castaldi PA (1989) Bernard\u2013Soulier syndrome. Baillieres Clin Haematol 2:585\u2013607","journal-title":"Baillieres Clin Haematol"},{"key":"1080_CR6","first-page":"1174","volume":"101","author":"FW Bouwmeester","year":"2003","unstructured":"Bouwmeester FW, Jonkhoff AR, Verheijen RH, van Geijn HP (2003) Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 101:1174\u20131176","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"1080_CR7","first-page":"150","volume":"26","author":"N Ciavarella","year":"1996","unstructured":"Ciavarella N, Schiavoni M, Valenzano E, Mangini F, Inchingolo F (1996) Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand\u2019s disease and an inhibitor against von Willebrand factor. Haemostasis 26(Suppl 1):150\u2013154","journal-title":"Haemostasis"},{"key":"1080_CR8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0037-1613884","volume":"83","author":"R d\u2019Oiron","year":"2000","unstructured":"d\u2019Oiron R, Menart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, Laurian Y, Negrier C (2000) Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann\u2019s thrombasthenia undergoing invasive procedures. Thromb Haemost 83:644\u2013647","journal-title":"Thromb Haemost"},{"key":"1080_CR9","doi-asserted-by":"crossref","first-page":"23776","DOI":"10.1016\/S0021-9258(18)54350-7","volume":"266","author":"L Marco De","year":"1991","unstructured":"De Marco L, Mazzucato M, Masotti A, Fenton JW, Ruggeri ZM (1991) Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin. J Biol Chem 266:23776\u201323783","journal-title":"J Biol Chem"},{"key":"1080_CR10","first-page":"615","volume-title":"Thrombosis and hemorrhage","author":"LC Dunlop","year":"1994","unstructured":"Dunlop LC, Andrews RK, Berndt MC (1994) Congenital disorders of platelet function. In: Loscalzo J, Schafer AI (eds) Thrombosis and hemorrhage. Blackwell Scientific, Boston, p 615"},{"key":"1080_CR11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0952-8180(03)00034-5","volume":"15","author":"RP Dutton","year":"2003","unstructured":"Dutton RP, Hess JR, Scalea TM (2003) Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 15:184\u2013188","journal-title":"J Clin Anesth"},{"key":"1080_CR12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0037-1613878","volume":"83","author":"RE Grossman","year":"2000","unstructured":"Grossman RE, Geisen U, Schwender S, Keller F (2000) Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with Type III von Willebrand\u2019s disease and alloantibodies against von Willebrand factor. Thromb Haemost 83:633\u2013634","journal-title":"Thromb Haemost"},{"key":"1080_CR13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","volume":"85","author":"M Hoffman","year":"2001","unstructured":"Hoffman M, Monroe DM (2001) A cell-based model of hemostasis. Thromb Haemost 85:958\u2013965","journal-title":"Thromb Haemost"},{"key":"1080_CR14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-2000-8459","volume":"26","author":"M Hunault","year":"2000","unstructured":"Hunault M, Bauer KA (2000) Recombinant factor VIIa for the treatment of congenital factor VII deficiency. Semin Thromb Hemost 26:401\u2013405","journal-title":"Semin Thromb Hemost"},{"key":"1080_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.2004.04878.x","volume":"125","author":"M Kaleelrahman","year":"2004","unstructured":"Kaleelrahman M, Minford A, Parapia LA (2004) Use of recombinant factor VIIa in inherited platelet disorders. Br J Haematol 125:95\u201396","journal-title":"Br J Haematol"},{"key":"1080_CR16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(99)05155-7","volume":"354","author":"G Kenet","year":"1999","unstructured":"Kenet G, Walden R, Eldad A, Martinowitz U (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879","journal-title":"Lancet"},{"key":"1080_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V92.1.175.413a36_175_183","volume":"92","author":"D Kenny","year":"1998","unstructured":"Kenny D, Jonsson OG, Morateck PA, Montgomery RR (1998) Naturally occurring mutations in glycoprotein Ibalpha that result in defective ligand binding and synthesis of a truncated protein. Blood 92:175\u2013183","journal-title":"Blood"},{"key":"1080_CR18","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1182\/blood.V93.9.2968","volume":"93","author":"D Kenny","year":"1999","unstructured":"Kenny D, Morateck PA, Gill JC, Montgomery RR (1999) The critical interaction of glycoprotein (GP) IBbeta with GPIX\u2014a genetic cause of Bernard\u2013Soulier syndrome. Blood 93:2968\u20132975","journal-title":"Blood"},{"key":"1080_CR19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2141.2004.05171.x","volume":"127","author":"C Kessler","year":"2004","unstructured":"Kessler C (2004) Haemostasis.com: clinical experiences in the investigational use of rFVIIa in the management of severe haemorrhage. Br J Haematol 127:230","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"1080_CR20","first-page":"159","volume":"26","author":"J Kristensen","year":"1996","unstructured":"Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U (1996) Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 26(Suppl 1):159\u2013164","journal-title":"Haemostasis"},{"key":"1080_CR21","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(99)01264-7","volume":"354","author":"M Levi","year":"1999","unstructured":"Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E, Buller HR (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:1940\u20131947","journal-title":"Lancet"},{"key":"1080_CR22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7326\/0003-4819-138-1-200301070-00028","volume":"138","author":"F Locatelli","year":"2003","unstructured":"Locatelli F, Rossi G, Balduini C (2003) Hematopoietic stem-cell transplantation for the Bernard\u2013Soulier syndrome. Ann Intern Med 138:79","journal-title":"Ann Intern Med"},{"key":"1080_CR23","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood.V91.12.4397","volume":"91","author":"JA Lopez","year":"1998","unstructured":"Lopez JA, Andrews RK, Afshar-Kharghan V, Berndt MC (1998) Bernard\u2013Soulier syndrome. Blood 91:4397\u20134418","journal-title":"Blood"},{"key":"1080_CR24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0037-1614475","volume":"81","author":"M Margaglione","year":"1999","unstructured":"Margaglione M, D\u2019Andrea G, Grandone E, Brancaccio V, Amoriello A, Di Minno G (1999) Compound heterozygosity (554\u2013589 del, C515-T transition) in the platelet glycoprotein Ib alpha gene in a patient with a severe bleeding tendency. Thromb Haemost 81:486\u2013492","journal-title":"Thromb Haemost"},{"key":"1080_CR25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1423-0410.1999.7730131.x","volume":"77","author":"G Mariani","year":"1999","unstructured":"Mariani G, Testa MG, Di Paolantonio T, Molskov BR, Hedner U (1999) Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies. Vox Sang 77:131\u2013136","journal-title":"Vox Sang"},{"key":"1080_CR26","first-page":"S15","volume":"49","author":"U Martinowitz","year":"2002","unstructured":"Martinowitz U, Kenet G, Lubetsky A, Segal E (2002) Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anaesth 49:S15\u2013S20","journal-title":"Can J Anaesth"},{"key":"1080_CR27","first-page":"431","volume":"51","author":"U Martinowitz","year":"2001","unstructured":"Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M (2001) Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51:431\u2013439","journal-title":"J Trauma"},{"key":"1080_CR28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001721-200104000-00008","volume":"12","author":"K Meijer","year":"2001","unstructured":"Meijer K, Peters FT, van der Meer J (2001) Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand\u2019s disease, controlled with recombinant factor VIIa. Blood Coagul Fibrinolysis 12:211\u2013213","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1080_CR29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.ATV.0000047645.37970.AB","volume":"23","author":"DM Monroe","year":"2003","unstructured":"Monroe DM, Roberts HR (2003) Mechanism of action of high-dose factor VIIa: points of agreement and disagreement. Arterioscler Thromb Vasc Biol 23:8\u20139","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1080_CR30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood.V96.2.532","volume":"96","author":"N Moran","year":"2000","unstructured":"Moran N, Morateck PA, Deering A, Ryan M, Montgomery RR, Fitzgerald DJ, Kenny D (2000) Surface expression of glycoprotein Ib alpha is dependent on glycoprotein Ib beta: evidence from a novel mutation causing Bernard\u2013Soulier syndrome. Blood 96:532\u2013539","journal-title":"Blood"},{"key":"1080_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","volume":"114","author":"F Moscardo","year":"2001","unstructured":"Moscardo F, Perez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA (2001) Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 114:174\u2013176","journal-title":"Br J Haematol"},{"key":"1080_CR32","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF03018648","volume":"50","author":"VN Naik","year":"2003","unstructured":"Naik VN, Mazer CD, Latter DA, Teitel JM, Hare GM (2003) Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass. Can J Anaesth 50:599\u2013602","journal-title":"Can J Anaesth"},{"key":"1080_CR33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0037-1615209","volume":"80","author":"M Peters","year":"1998","unstructured":"Peters M, Heijboer H (1998) Treatment of a patient with Bernard\u2013Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost 80:352","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"1080_CR34","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00001721-200004001-00013","volume":"11","author":"MC Poon","year":"2000","unstructured":"Poon MC, d\u2019Oiron R (2000) Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International registry on recombinant factor VIIa and congenital platelet disorders group. Blood Coagul Fibrinolysis 11(Suppl 1):S55\u2013S68","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1080_CR35","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V94.11.3951","volume":"94","author":"MC Poon","year":"1999","unstructured":"Poon MC, Demers C, Jobin F, Wu JW (1999) Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 94:3951\u20133953","journal-title":"Blood"},{"issue":"Suppl 1","key":"1080_CR36","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00001721-200306001-00007","volume":"14","author":"S Seremetis","year":"2003","unstructured":"Seremetis S (2003) Dose optimization of recombinant factor VIIa in the treatment of acute bleeding in haemophilia-associated inhibitors. Blood Coagul Fibrinolysis 14(Suppl 1):S29\u2013S30","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1080_CR37","first-page":"230","volume":"73","author":"S Sobieszczyk","year":"2002","unstructured":"Sobieszczyk S, Breborowicz GH, Markwitz W, Mallinger S, Adamski D, Kruszynski Z (2002) Effect of recombinant activated factor VII (RFVIIA; NovoSeven) in a patient in haemorrhagic shock after obstetrical hysterectomy. Ginekol Pol 73:230\u2013233","journal-title":"Ginekol Pol"},{"key":"1080_CR38","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000542-200306000-00034","volume":"98","author":"KA Tanaka","year":"2003","unstructured":"Tanaka KA, Waly AA, Cooper WA, Levy JH (2003) Treatment of excessive bleeding in Jehovah\u2019s Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology 98:1513\u20131515","journal-title":"Anesthesiology"},{"key":"1080_CR39","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1023\/A:1019605803467","volume":"47","author":"HR Buuren van","year":"2002","unstructured":"van Buuren HR, Wielenga JJ (2002) Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann\u2019s thrombasthenia. Dig Dis Sci 47:2134\u20132136","journal-title":"Dig Dis Sci"},{"key":"1080_CR40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0609.1991.tb01274.x","volume":"46","author":"E Waldenstrom","year":"1991","unstructured":"Waldenstrom E, Holmberg L, Axelsson U, Winqvist I, Nilsson IM (1991) Bernard\u2013Soulier syndrome in two Swedish families: effect of DDAVP on bleeding time. Eur J Haematol 46:182\u2013187","journal-title":"Eur J Haematol"},{"key":"1080_CR41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000064699","volume":"108","author":"SS Zupancic","year":"2002","unstructured":"Zupancic SS, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M (2002) Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol 108:162\u2013163","journal-title":"Acta Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-1080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-005-1080-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-1080-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:09:48Z","timestamp":1626221388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-005-1080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1080"],"URL":"https:\/\/doi.org\/10.1007\/s00277-005-1080-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,12]]}}}